PETALING JAYA: As Malaysia’s Covid-19 vaccination programme picks up steam, companies that have ventured into the procurement and distribution of vaccines are set to benefit from such deals in the form of boosters to their income streams.
According to MIDF Research head Imran Yassin, the key challenge will be the procurement of the vaccine itself.
“However, it seems that, for now, this is manageable. Besides, the varied sources of the vaccines will mitigate some of the concerns as we do not have to rely on one producer, which may lead to bottlenecks and delays in the delivery of vaccines,” he told SunBiz.
As Malaysia grapples with containing the Covid-19 pandemic, an accelerated vaccine rollout has been touted as a viable solution to its woes and set it on the right track towards economic reopening and recovery
In developed economies such as the US and the UK, inoculation efforts have managed to turn around their struggles with the pandemic and brought them to the path of economic recovery.
The UK has logged an estimated 4.7 million Covid-19 cases to date, out of a population of 66.65 million. Since the rollout of vaccination, the country has eased curbs on certain sectors and sports events are allowed subject to conditions.
In recent weeks, the US has seen its 7-day average of new Covid-19 infections flatten to below 20,000 from a peak of 300,628 on Jan 8 after slightly more than half its population of 332 million have received at least one dose of vaccine.
With such empirical evidence, Imran opined that Malaysia’s economic recovery depends on the success of its vaccination programme. “Should herd immunity be achieved earlier, we believe that the country’s economic recovery will move in tandem and can also be achieved earlier,” he said.
Science, Technology, and Innovation Minister Khairy Jamaluddin, who serves as the National Covid-19 Immunisation Programme (NCIP) coordinating minister, announced on Thursday that the federal government is allowing state governments and private hospitals to purchase vaccines other than those used in the federal programme, provided they are approved by the World Health Organisation (WHO).
He said they could source vaccines from the same suppliers as the federal government, namely Sinovac and BioNtech-Pfizer, although the national vaccination programme’s orders will be fulfilled first.
Apart from Sinovac and BioNtech-Pfizer, WHO has approved AstraZaneca, Sinopharm, Serum Institute of India, Janssen and Moderna vaccines for emergency use.
In addition, the NCIP has increased the number of mega vaccination centres. On June 21, the NCIP included Bukit Jalil National Stadium in its list of mega vaccine centres. The stadium joins Kuala Lumpur Convention Centre, Setia City Convention Centre and three other mega vaccine centres that came online on June 7.
Imran views the efforts to ramp up vaccination in positive light and the immunisation objective is within reach. “The key now is to convince more rakyat to be inoculated, which is a shared responsibility and not just the government’s.”
Companies with vaccine deals:
KANGER INTERNATIONAL BHD
Deal: Entered into an agreement for the dealership and distribution of Sinopharm’s Covid-19 vaccine. Inked MoU with Sabah state government for the procurement and import of Sinopharm’s vaccine.
Status: Awaiting delivery schedule from vaccine supplier.
Hopefully wont go too bad. On technical seems that kanger had go to the worst now.
But still to reflect REBOUND SIGNAL should look forward to next QR, as long the government not making any further announcement regarding market recovery plan, the market will keep go worst and more worst.
One of the quickest and most effective way of gauging if a company is “trustworthy” would be on the act of its management. This is fairly straightforward, given that if the management owns a huge chunk of share in the company, the ultimate reward – in share price would benefit them as long as they performed well.
Recently, Kanger International Berhad (0170) two good news to be announced. The first one being the company had received an extension of time granted by Ganzhou Bank Co., Ltd for the repayment of RMB60 million loan. So far, KANGER had only repaid RMB8 million in the loan.
The extension of repayment signifies a vote of confidence from Ganzhou Bank Co., Ltd to KANGER, which I expect them to have interesting stories moving forward.
Next, if we backdate to 26th April 2021, KANGER had also ventured into a share sale agreement with Sii family to purchase 51% stake of Sung Master Holdings Sdn Bhd for a total consideration of RM94.8 million.
As we mention earlier, one of the best way to gauge the trustometer of a company is the act of the management.
Under ordinary resolution 1 for KANGER’s upcoming EGM, the company proposed to complete the acquisition exercise of the building material supplier Sung Master. The way of settlement would be RM51.9 million in cash and RM42.7 million in new shares issuance.
Of course, issuance of new shares is not a problem for the company. How about the cash part?
In KANGER’s latest quarterly report, it clearly shows that the company had more than enough cash for the settlement of the purchase.
But the management would take this acquisition to another level.
As you can see, under the ordinary resolution 2 of the company, the existing key management and shareholder of the company – Mr. Kuah Choon Ching had showed an additional vote of confidence by agreed to subscribe 769,513,179 shares at 6 cents each to fund the acquisition.
In short, Mr. Kuah is very confident in the acquisition to invest over RM40 million into the acquisition.
Also, KANGER’s share price had actually bottomed at the current level. It seems like all risks are extremely low for now. What are your thoughts on the company?
The Current Status of MOUs and Agreements Relating To KANGER (0170)
Started from August 2020, Kanger (0170) has signed several Memorandum of Understandings (MOUs) and agreement with several parties to start several business opportunities. The current status of the MOUs and agreements are as follows:
1. A Collaboration Agreement between Vegetta Champion Sdn. Bhd. and Kanger Ventures Sdn. Bhd. a wholly owned subsidiary of Kanger, relating to a Genting Highland construction project contract with contract value RM478 million.
Progress of the agreement:
a) Based on an announcement at BURSA dated 2 March 2021. - VCSB received a Letter of Intent dated 2 March 2021, whereby VCSB was appointed as the main contractor for foundation and main building works of a project. - Kanger Ventures shall be responsible for the entire project management, financial and entire administration of the Project
b) Based on an announcement at BURSA dated 4 March 2021. - The Company announced that the Project is expected to commence in June 2021 and to be completed in 48 Months.
Remarks: The construction project contract under this agreement will start in June 2021.
2. MOUs between Kanger and several parties, relating to the company’s efforts to secure as a distributor for Sinopharm Covid-19 vaccines in Malaysia.
Remarks: These MOUs is in progress and awaiting for NPRA’s approval for the Sinopharm Covid-19 vaccines before Kanger probably can execute the deal to import and distribute the vaccines in Malaysia.
3. A Conditional Sale Agreement (SSA) between Kanger and Vendors, relating to the proposed acquisition of 1,020,000 ordinary shares of Sung Master, representing 51.0% equity interest of Sung Master.
Progress of the agreement:
a) Based on an announcement at BURSA dated 26 April 2021. - The company proposed acquisition of 1,020,000 ordinary shares of Sung Master, representing 51.0% equity interest of Sung Master for a purchase consideration of RM94,789,436.00. - The Purchase Consideration shall be satisfied via a combination of cash payment of RM51,999,999.62 whilst the remaining purchase consideration of RM42,789,436.38 shall be satisfied via the issuance of 713,157,273 new ordinary shares of Kanger at the issue price of RM0.06 per Kanger Share.
b) Based on an announcement at BURSA dated 12 May 2021. - The company announced that the listing application for the Proposals has been submitted to Bursa Malaysia Securities Berhad on 12 May 2021.
Remarks: This agreement is in progress and awaiting for approval from the authority’s approval and the completion of the proposed Right Issue (RI) with warrants exercises.
4. A Conditional Sale and Purchase Agreement (SPA) between Kanger Ventures Sdn Bhd and Aset Kayamas Sdn Bhd, relating to the proposed acquisition of serviced apartments located @ Genting Highlands, Bentong, Pahang.
Progress of the agreement:
a) Based on an announcement at BURSA dated 24 February 2021. - The company announced the acquisition proposal by Kanger Ventures Sdn Bhd , a wholly-owned subsidiary of Kanger, of 126 units of proposed serviced apartments located on the 30th to 45th floors of Tower A, Antara @ Genting Highlands, Bentong, Pahang from the developer, namely Aset Kayamas Sdn Bhd for a total purchase consideration of RM142,870,000 to be satisfied entirely via cash.
b) Based on an announcement at BURSA dated 19 April 2021. - The company announced that the listing application pursuant to the Proposals has been submitted to Bursa Malaysia Securities Berhad on 19 April 2021.
c) Based on an announcement at BURSA dated 26 April 2021. - The company announced that the Board had on 26 April 2021 ("Price-Fixing Date") resolved to fix the issue price of the Rights Shares at RM0.06 per Rights Share .
d) Based on an announcement at BURSA dated 2 June 2021. - The company announced that the Bursa Securities vide its letter dated 2 June 2021, resolved to approved the following:- i. Admission to the Official List and listing and quotation of up to 2,861,936,149 Warrants B to be issued pursuant to the Proposed Rights Issue with Warrants;
ii. Listing and quotation of:- Up to 2,861,936,149 new Kanger Shares to be issued pursuant to the Proposed Rights Issue with Warrants; and
Remarks: This agreement in progress and awaiting for the completion of the proposed Right Issue (RI) with warrants exercises.
5. A Collaboration Agreement between Kanger Ventures and Multiple Novation, relating to a multiple constructions works.
Progress of the agreement:
a) Based on an announcement at BURSA dated 15 January 2021
The Board of Directors of Kanger International wishes to announce that its wholly-owned subsidiary, Kanger Ventures Sdn Bhd, had on 15 January 2021 entered into the following Collaboration Agreements.
a) Qbeez Holdings Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 6th July 2018 for construction of main building works of the project of development of three (3) blocks of affordable apartment on Lot 52957, Jalan Desa, Taman Desa, Mukim Kuala Lumpur, Wilayah Persekutuan (“Qbeez Project 1”);
b) Qbeez Holdings Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 28th December 2018 for construction of building and external works for the project of development two (2) blocks apartment on PT 15659, Jalan Indrahana 3, Mukim Petaling, Kuala Lumpur, Wilayah Persekutuan (“Qbeez Project 2”);
c) Lead Pinnacle Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 28th October 2019 for construction of piling and foundation works of the project of construction of a temporary gallery on PT 23923, (H.S.(D) 18603) Genting Highlands, Mukim Bentong, Daerah Bentong, Negeri Pahang (“Lead Project 1”);
d) Lead Pinnacle Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 7th July 2020 for construction of foundation and main building works for the project of a mixed development of two (2) blocks of service apartment on PT 23923, (H.S.(D) 18603) Genting Highlands, Mukim Bentong, Daerah Bentong, Negeri Pahang (“Lead Project 2”);
e) Deseo Engineering Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 13th April 2018 for construction of main building works for the project of a development of two (2) blocks of affordable apartments and two (2) blocks of apartment on Lot 55121, Jalan Jujur, Bandar Tun Razak, Cheras, Kuala Lumpur (“Deseo Project”);
f) Enduring Power Sdn Bhd and Kanger Ventures in respect of Letter of Award dated 1st June 2019 for construction of main building works for the project of a development of two (2) blocks of service apartment on Lot 1351 & 1377, Jalan Padang/Jalan Padang Walter Grenier dan sebahagian simpanan Jalan, Seksyen 67, Bukit Bintang, Bandar Kuala Lumpur (“Enduring Project”).
- Any approval required from the relevant authority and shareholders in a general meeting of the Company to undertake this collaboration herein contemplated; - The Parties shall fulfill the above conditions within 90 (ninety) days from the date of these agreements or such extended date as shall be mutually agreed in writing by the Parties (Cut-Off Date).
Remarks: No further announcement on the progress of this Collaboration Agreement yet by to date.
6. A Head of Agreement between Kanger and Constellation Holdings Ltd, Dubai regarding the setting up of medical examination gloves manufacturing operations in Malaysia.
Progress of the agreement:
a) Based on an announcement at BURSA dated 11 August 2020.
- The company has received a formal Expression of Interest letter (“EOI”) dated 9 August 2020 from Constellation Holdings Limited, Dubai for collaboration in the setting up of medical examination gloves operations in Malaysia.
b) Based on an announcement at BURSA dated 14 August 2020.
- The company had, on 13 August 2020 entered into a heads of agreement with Constellation Holdings Limited. - Kanger is setting up a glove manufacturing plant in Ijok, Selangor for about RM77 million. - Kanger has incorporated a wholly-owned subsidiary, Kanger Glove Manufacturing Sdn Bhd, which will acquire around five acres in Ijok for RM6.8 million. - Kanger Glove would spend RM70 million to build the plant and install up to eight production lines to produce medical, surgical and/or nitrile glove.
c) Based on an announcement at BURSA dated 21 August 2020.
- The Company provided additional information pursuant to the queries by BURSA. - The company need to apply for the relevant regulatory approvals for setting up the factory.
Remarks: No further announcement or report on the progress of this medical examination gloves manufacturing operations can be retrieved by the writer yet by to date.
13-07-2021 news above: With the latest development, Saudi Arabia now recognises six types of vaccines, namely Pfizer-BioNTech, Moderna, AstraZeneca, Janssen, Sinopharm and Sinovac.
Hahaha keluat balik article panjang2. Cut in short, this is con counter, jual article, jual MoU untum tarik bilis, bilis dah masuk semua tak bolih kluar, avoid tis counter at any cost gang
@punterdanny. Semua hanya dibuat atas andaian dengan baca berita di internet saja. Saya bukan profesional dan bukan insider. Apa-apa pun TAYOR..
Report 5: 24 June 2021.
“I also anticipate by about August, we will have a private vaccine market. So right now, it’s difficult for private because vaccines are in short supply. But by August, I think that there will be some companies who will be approved to bring in some private vaccines from China. I know SINOPHARM and all that are going to be registered here,” Khairy added.
“That’s also part of the plan. I’ve been talking to the Ministry of Health to ensure that the private market by August can take off to help us.”
Malaysia fully vaccinated by august, sinopharm masuk by augusy, the time sinopharm masuk orang dah vaccinated, nanti sinopharm bolih cucuk kasi lembu, nanti lembu jadi cerdik, hahaha, what the fuxx
As for now, 12M vaccinated!!!! Daily rate 450k ongoing..... Kanger nk tunggu bulan august, lulus pun belum nk cerita pasal nl supply vaksin, taik kucing la kanger. Buat MoU sampai lubang kubur laaaa
August coming soon. Mahathir spoke many times supporting Chinese vaccine. Malaysian Singaporean go where for cool holidays after covid? Bamboo factory in Miao and Dong area, Kanger gives job to them, win win situation. So, i am getting ready bullets for RI:)
3. A Conditional Sale Agreement (SSA) between Kanger and Vendors, relating to the proposed acquisition of 1,020,000 ordinary shares of Sung Master, representing 51.0% equity interest of Sung Master.
Progress of the agreement:
a) Based on an announcement at BURSA dated 26 April 2021. - The company proposed acquisition of 1,020,000 ordinary shares of Sung Master, representing 51.0% equity interest of Sung Master for a purchase consideration of RM94,789,436.00. - The Purchase Consideration shall be satisfied via a combination of cash payment of RM51,999,999.62 whilst the remaining purchase consideration of RM42,789,436.38 shall be satisfied via the issuance of 713,157,273 new ordinary shares of Kanger at the issue price of RM0.06 per Kanger Share.
b) Based on an announcement at BURSA dated 9 July 2021. - The company announced that the notice of EGM is called for the voting of the resolutions on the proposed acquisition of Sung Master and the proposed subscription of 769,513,179 new Kanger Shares at the subscription price of RM0.06 per subscription share by Mr. Kuah Choon Hing. - The scheduled date of EGM is on 27 July 2021.
Remarks: This agreement is in progress and awaiting for approval from the authority’s approval and the approval from investors in incoming EGM.
DO YOU HAVE ANY COMMENT ABOUT THESE PLANS BY KANGER? PLEASE BE OBJECTIVE ABOUT IT. IF YOU CAN, PLEASE GIVE ANY PRO OR CON ABOUT THE COMPANY'S PLANS OF DEVELOPMENT.....
Kanger is still in progressing state in its current business, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities.
1. The company already involved in construction services.
2. In a process to acquire property for investment.
3. In a process to acquire a company which involved in a construction material trading.
4. And of course a plan for Covid-19 vaccine business, they just in the process of trying to secure the said business. It's true to say that the most critical aspect to get is the approval of Sinopharm vaccine in Malaysia by the government/NPRA. Waiting for August 2021 and hope for a clearer picture concerning the approval of the Sinopharm Covid-19 Vaccine by NPRA.
KOTA KINABALU: The Construction Industry Vaccination Program (CIVac) will be extended to Sabah in the earliest possible future.
Dr Roland Chia Ming Shen, director of Construction Industry Development Board (CIDB) Malaysia, disclosed on Monday.
He said a special task force had been set up in Sabah to expedite CIVAc in Sabah. The task force will comprise of federal and state agencies and the stakeholders of the construction industry namely the developers, builders, professional consultants and hardware materials operators.
This is in line with the Federal Minister of Works and the Chief Minister of Sabah’s call to expedite the vaccination program for the construction industry in Sabah.
The Construction Industry Development Board Malaysia through CIDB Holdings Sdn Bhd (a wholly own subsidiary of CIDB Malaysia) which is an agency under the Federal Ministry of Works, has introduced the CIVac to accelerate the vaccination uptake among the construction workforce to achieve herd immunity and reduce the Covid-19 workplace clusters.
This program aims at protecting the well-being of employees in the construction industry and subsequently facilitate in expediting Malaysia’s economic recovery.
CIVac is to complement the National Covid-19 Immunisation Program (PICK).
Through CIVac, members of the industry in Sabah may register for the vaccination programme.
The vaccines are provided free of charge but the employers will need to pay for administrative cost of RM90 per person to cover the medical facilities and venue expenses as CIVac is a public-private initiative.
As for now, 12M vaccinated!!!! Daily rate 450k ongoing..... Kanger nk tunggu bulan august, lulus pun belum nk cerita pasal nl supply vaksin, taik kucing la kanger. Buat MoU sampai lubang kubur laaaa 13/07/2021 6:49 PM
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MZM2511
4,548 posts
Posted by MZM2511 > 2021-07-12 15:20 | Report Abuse
Khairy Projects 40% Population Fully Vaccinated By End August